Although numerous studies suggesting the involvement of FBXO11 in tumor progression [12, 19, 20], PRMT9-mediated arginine methylation modifications in tumors have not been studied much, limited by the short time frame of the studies. The gene discussed is FBXO11; the disease is neoplasm.